Professor Nicolas Bazan, USA |
 | Nicolas Bazan is a medical graduate from Tucuman, Argentina. He has senior
postings at Columbia University ,and Harvard Med. School, the Clarke
Institute, Univ. Toronto, Canada and Founding Director, Institute of
Biochemical Research, University of South, Argentina. Since 1981 he has
been Professor of the LSU School of Medicine and Founding Director,
Neuroscience Center. His lab has reported major findings on brain ischemia
or seizures onand AA and DHA release, identification of supraenoic
molecular species of phospholipids, liver derived DHA used duringduring
development ofto photoreceptors and brain, PAF synaptic and intracellular
binding sites and PAF-mediated gene expression regulation, PAF as a
retrograde messenger of LTP, they have identified neuroprotective
docosanoids and defined their significance in macular degeneration,
stroke and Alzheimers disease.
Abstract: DOCOSAHEXAENOIC ACID SIGNALING IN AGING, STROKE AND ALZHEIMERS DISEASE [PDF] |
Professor Philip Calder, UK |
 | Philip Calder is Professor of Nutritional Immunology at the University of Southampton, United Kingdom. He has been studying the influence of dietary fatty acids on aspects on human health, in particular in relation to cardiovascular disease, inflammation and immunity, since 1987. In 1995 he was awarded the Sir David Cuthbertson Medal by the UK Nutrition Society for this work and he was awarded the Belgian Danone Institute Chair for 2004. Professor Calder has served on committees of the UK Nutrition Society, the British Society of Immunology and the British Association for Parenteral and Enteral Nutrition (BAPEN). He currently serves on the Science and Research Committee of BAPEN and on the Scientific Committee of the European Society for Clinical Nutrition and Metabolism (ESPEN). He has been a member of the Board of Directors of ISSFAL, and has recently been elected ISSFAL Vice-President. Professor Calder is Editor-in-Chief of the British Journal of Nutrition and an Associate Editor of Clinical Science and of Lipids. He is also a member of the Editorial Boards of eight other journals including Biochimica et Biophysica Acta Molecular & Cell Biology of Lipids, Clinical Nutrition, Journal of Nutrition, and Prostaglandins Leukotrienes and Essential Fatty Acids. He is section editor of the "Lipid metabolism and therapy" section of Current Opinion in Clinical Nutrition and Metabolism, and Editor-in-Chief of the Frontiers in Nutritional Science series of books. He was overall chair of the 6th ISSFAL Congress.
Abstract: FATTY ACID ABNORMALITIES IN ATOPIC DISEASE: EVIDENCE EXAMINED AND ROLE IN THE DISEASE PROCESS EXPLORED [PDF] |
Professor Susan Carlson, USA |
 | Susan E Carlson, PhD is the Midwest Dairy Council Professor of Nutrition at the University of Kansas Medical Center in the Departments of Dietetics and Nutrition and Pediatrics and a Clinical Professor of Obstetrics and Gynaecology at the University of Missouri-Kansas City. Her research interests include the nutritional role of DHA in pregnancy and infant development. In 2002, she was made an honorary member of the American Dietetic Association for experimental studies of DHA and human development. Dr. Carlson is a charter member of ISSFAL and has been an organiser for two international conferences on the role of LCPUFA in maternal and infant health. |
Professor Les Cleland, Australia |
 | Les Cleland is a practising rheumatologist with a long term interest in the anti-inflammatory effects of fish oil and the omega-3 fatty acids therein, on production of inflammatory and vaso-active eicosanoids in healthy subjects, patients with arthritis and in various cell types, under hypoxic and normoxic conditions. He is also interested in the effects of fish oil on inflammatory cytokine production and cardiac arrhythmias. Recent activities include an ongoing study into the influence of anti-inflammatory doses of fish oil in the long term management of rheumatoid arthritis, within the context of modern, early intervention with combination chemotherapy. |
A/Professor Kevin Croft, Australia |
 | Kevin Croft is Associate Professor in the University of Western Australia School of Medicine and Pharmacology at Royal Perth Hospital. Major research interests are related to oxidative damage to lipids and atherosclerosis. This includes an interest in biomarkers of in vivo oxidative damage, role of endogenous as well as in diet derived antioxidants and the potential biological activity of lipid oxidation products. Professor Croft is president of the Australasian Society for Free Radical Research (2006-7).
Abstract: ANTIOXIDANTS - DO THEY DO ANYTHING? [PDF] |
Professor Stephen Cunnane Centre de recherche sur le vieillissement, University of Sherbrooke, Canada |
 | Stephen Cunnane has had an extensive career in lipid biochemistry. He joined the University of Toronto in 1986 where he developed NMR methods applicable to non-invasive studies of long chain fatty acid metabolism. He has been a pioneer in demonstrating the relatively large loss of polyunsaturates occuring through -oxidation. Dr Cunnane is currently a Canada Research Professor at the Research Center on Aging at the Sherbrooke University Geriatric Institute, Université de Sherbrooke, near Montreal. The theme of his current research is to learn more about whether the -oxidation of polyunsaturates may be contributing to energy substrate availability in the brain and thereby helping maintain cognitive function during aging.
He is the author of the recently published book on human brain evolution - Survival of the Fattest: The Key to Human Brain Evolution (http://www.worldscibooks.com/lifesci/5769.html) - and has also written a book on zinc nutrition, co-edited two books on flaxseed in human nutrition, and published over 200 research papers. |
A/Professor Kevin Fritsche, University of Missouri-Columbia |
 | Kevin Fritsche is an Associate Professor in the Division of Animal Sciences and the Departments of Nutritional Sciences as well as Molecular Microbiology & Immunology at the University of Missouri-Columbia. His primary research interest is exploring the impact of dietary fatty acids on infectious disease resistance and inflammation. His work has focused primarily on omega-3 fatty acids from plant and marine origins. He was a founding member of the nutrition-immunology research interest group within the American Society for Nutrition. He is also a member of the American Association of Immunologists as well as ISSFAL.
Abstract: IMPACT OF MODEST OMEGA-3 FATTY ACID SUPPLEMENTATION ON MURINE INFECTIOUS DISEASE RESISTANCE AND HEPATIC GENE PROFILES [PDF] |
Dr Derek Gilroy Department of Medicine, Rayne Institute, University College London |
 | Derek Gilroy obtained his PhD from the William Harvey Research Institute, University of London working on the role of inducible cyclooxygenase in inflammation with the late Professors Derek Willoughby and Sir John Vane. After postdoctoral training with Dr. Kenneth Wu, he returned to the William Harvey Research Institute for 4 years examining the molecular and biochemical pathways that regulates the resolution of acute immune reactions. In 2004, Derek was appointed as New Blood lecturer funded as a Wellcome Trust Career Development Fellow at the Department of Medicine, Rayne Institute, University College London. There, his research interests focus on the endogenous factors that control the resolution of acute innate and adaptive immunity as well as aspirin-triggered nitric oxide and the regulation of cell trafficking.
Abstract: LIPID MEDIATORS IN INFLAMMATORY RESOLUTION; NEW PERSPECTIVES ON THE INFLAMMATORY RESPONSE AND AN EMERGING ERA IN ANTI-INFLAMMATORY DRUG DEVELOPMENT [PDF] |
Dr Allan Green CSIRO, Australia |
 | Allan Green is a Senior Principal Research Scientist for CSIRO Plant Industry located in Canberra. His background is in plant breeding and genetics, and his main research activities have been in the genetic modification of fatty acid composition in oilseed crops for improved nutritional value, enhanced food functionality, and new industrial end uses.
His research group in CSIRO has successfully applied new methods of gene silencing to develop low-saturate, high-monounsaturate forms of canola and cottonseed oils. These provide nutritious and highly stable alternatives to current food service oils that have high levels of saturates and/or trans fatty acids. They are also involved in research to introduce new metabolic pathways into oilseeds to enable the synthesis of novel fatty acids of nutritional or industrial importance, including long-chain omega-3 PUFA.
Abstract: INCREASED SUPPLY OF LC-PUFA THROUGH PLANT BIOTECHNOLOGY [PDF] |
Dr Laurence S. Harbige, United Kingdom |
 | Laurence S. Harbige is a Reader in the Schools of Science and Pharmacy at the University of Kent and University of Greenwich and a visiting lecturer at the London School of Hygiene and Tropical Medicine (University of London) and University of Surrey. He started his career in the Department of Biochemistry headed by Professor Michael Crawford at the Nuffield Laboratories of Comparative Medicine following which he moved to the Department of Immunology, United Medical and Dental Schools of Guy's and St. Thomas's Hospitals (University of London). His main research interest is in the mechanisms by which polyunsaturated fatty acids affect immune cell functions and autoimmune-inflammatory disease particularly their role in the pathogenesis and treatment of multiple sclerosis. He was the founding member and first chairman of the British Society for Immunology's Nutritional Immunology Affinity Group and is a member of ISSFAL.
Abstract: POLYUNSATURATED FATTY ACIDS IN THE PATHOGENESIS AND TREATMENT OF MULTIPLE SCLEROSIS [PDF] |
Professor Tony Hulbert Australia |
 | Tony Hulbert grew up in Sydney and as an undergraduate he showed that marsupials had a low metabolic rate, which began a long-term research interest into the evolution of energy metabolism. He is currently at the Metabolic Research Centre at the University of Wollongong. With Paul Else, he developed the membrane pacemaker theory of metabolism. He recently extended this to examine the role of membrane lipids in ageing and in 2005 was a Fulbright Senior Scholar investigating this aspect of membrane lipids.
Abstract: MEMBRANE FATTY ACIDS AS PACEMAKERS OF ANIMAL METABOLISM [PDF] |
Professor Sheila Innis, Canada |
 | Sheila Innis is a Professor in the Department of Paediatrics, Director of the Nutrition Research Program, Child and Family Research Institute, and a Distinguished Scholar in the Faculty of Medicine, University of British Columbia. She has served on numerous regulatory and policy making panels including the National Academy of Sciences panel on macronutrient intakes, the Life Sciences Research Office panel on nutrient levels for term infant formulas, and the Health Canada Task Force on the reduction of trans fats in Canadian foods. Dr Innis has over 160 peer reviewed papers on essential fatty acids, focusing mainly on maternal and infant nutrition.
Abstract: BIOACTIVE LIPIDS AND THEIR NUTRIENT INTERACTIONS. [PDF] |
Dr Michael James Royal Adelaide Hospital, Australia |
 | Michael James is a scientist in the Rheumatology Unit, Royal Adelaide Hospital. He is also Chairman of the Human Research Ethics Committees at the Royal Adelaide Hospital and at the Cancer Council of South Australia. He is a Board member of ISSFAL and of the Australian Institute of Health Law and Ethics. His research interests in the health benefits of n-3 fatty acids encompass a research interest in eicosanoid synthesis. He has published extensively on the biochemisty of regulation and activity of COX-2 under various conditions and with his colleague, Les Cleland, sounded early warnings about cardiovascular risk with selective COX-2 inhibitors.
Abstract: COX-2 INHIBITORS: BIOLOGY, ETHICS, LAW [PDF] |
Dr Jing Kang Department of Medicine, Massachusetts General Hospital & Harvard Medical School, USA |
 | Jing X Kang, MD, PhD is an Associate Professor of Medicine at Harvard Medical School and a principal investigator at the Massachusetts General Hospital. He studies the health effects of omega-3 polyunsaturated fatty acids, how they work and how genetic technologies can be used to further their benefits. His studies have demonstrated the protective effects of the fatty acids against cardiac arrhythmias and sudden death.
Using genetic approaches, he is exploring the feasibility of modifying essential fatty acid composition (omega-6/omega-3 ratio) of animal cells and creating transgenic "omega-3" animals for research and for foods.
Abstract: A TALE OF OMEGA-3: FROM FAT TO FAT-1 [PDF] |
Dr. Hee-Yong Kim Section of Mass Spectrometry, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, USA |
 | Hee-Yong Kim is Chief of the Section of Mass Spectrometry, Laboratory of
Membrane Biochemistry and Biophysics at the National Institute on Alcohol
Abuse and Alcoholism, NIH, USA. She is also Adjunct Professor of the
Department of Chemistry at the University of Memphis and School of
Pharmacy Medical College of Virginia Commonwealth University. Her
research interest has been membrane biochemistry and related signaling
leading to cell survival and differentiation in the neuronal system. For
characterization of membrane phospholipid remodeling and membrane-protein
/ protein-protein interactions involved in cell signaling, she develops
and uses mass spectrometric methodology extensively. Over the past 15
years, her group has published over 60 peer reviewed papers, leading to an
understanding of underlying mechanisms for the essential function of
polyunsaturates, especially docosahexaenoic acid in brain.
Abstract: NEUROTROPHIC EFFECTS OF DOCOSAHEXAENOIC ACID; MECHANISTIC INVESTIGATION [PDF] |
Professor Bert Koletzko University of Munich, Germany |
 | Berthold V. Koletzko, M.D., Ph.D. is Professor of Paediatrics and Head of the Div. Metabolic Diseases and Nutritional Medicine at the Hauner Children's Hospital, University of Munich, Ger-many. His research is on metabolism and nutrition in childhood, pregnancy & lactation, metabolic diseases, and clinical nutrition, with a particular focus on lipid and fatty acid metabolism since the 1980ies. Bert has co-authored more than 500 publications and received numerous scientific awards and honors. He coordinates the the European Research Programme on Early Nutrition Programming of Adult Health (www.metabolic-programming.org). Bert serves as Chair of the Committee on Nu-trition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (www.espghan.org) and as President of the German Society for Clinical Nutrition (www.dgem.de). |
Professor Penny Kris-Etherton Pennsylvania State University |
 | Dr Penny Kris-Etherton completed her PhD in Human Nutrition from the University of Minnesota, was a Postdoctoral Research Fellow at Stanford University in lipid metabolism the Division of Gastronenterology and became an Assistant Professor of Nutrition and ADA Plan IV Program Director at Pennsylvania State University. Dr Kris-Etherton was promoted to Associate Professor in 1985 and Full Professor in 1989. She is currently Distinguished Professor of Nutrition.
The emphasis of Dr Kris-Etherton's research program is on exploring how nutrients and other bioactive constituents affect established and emerging risk factors for cardiovascular disease. Dr.Kris-Etherton also has actively explored the health effects of fatty acids with emphasis on stearic acid, monounsaturated fatty acids and omega-3 fatty acids. Furthermore, throughout her career she has played a role in the widespread communication of nutrition messages to health professionals, government representatives, consumers and the media. Dr Kris-Etherton has published over 150 scientific papers, 10 book chapters and co-authored 4 books. Her research program has been funded by NIH, USDA and the private sector. She is the recipient of the Lederle Award for Human Nutrition Research awarded in 1991 by the American Society for Nutritional Sciences and in 1998 she was selected for the Foundation Award for Excellence in Research by the American Dietetic Association and became a Fellow in the American Heart Association in 2001. In 2005, she received the Elaine Monsen Research Award from the American Dietetic Association Foundation |
Dr Yolanda Lombardo, Argentina |
 | Yolanda Lombardo is Professor of Biochemistry and Head of the Department of Biological Sciences at the Universidad del Litoral Santa Fe, Argentina. She is Visiting Professor of the: University of Pittsburgh, Medical College of Wisconsin, Milwaukee and Universidad San Pablo, CEU, Madrid, España. Dr Lombardo is also Visiting Scientist of The Garvan Institute of Medical Research, University of New South Wales, Sydney, Australia and Department of Diabetes, Hotel Dieu Hospital, Paris, France. She has numerous publications in international journals in the field of experimental models of dyslipidemia, obesity and insulin resistance.
Abstract: OMEGA 3 PUFA & THE METABOLIC SYNDROME [PDF] |
Dr Maria Makrides Child Health Research Institute, Adelaide, Australia |
 | Maria Makrides is a Dietitian, Senior Research Fellow of the National Health & Medical Research Council (Australia) and was recently appointed Director, Child Nutrition Research Centre (Adelaide). Her main research focus is in evidence based nutritional approaches to improve the health outcomes of women & their children. She has published more than 60 peer reviewed articles and leads the investigative teams of two major multi-centre randomised controlled trials in perinatal lipid nutrition.
Abstract: SYSTEMATIC REVIEWS AND LARGE SCALE RANDOMISED CONTROLLED TRIALS: WE’VE COME A LONG WAY BABY! [PDF] |
Joyce A. Nettleton, DSc, RD
|
 | Dr. Nettleton is a nutrition scientist specializing in seafood nutrition. She has an independent consulting practice, ScienceVoice Consulting, in Denver, CO.
Nettleton is well known for her work in seafood nutrition. She has written three books on the subject, including Omega-3 Fatty Acids and Health, published in 1995. Nettleton is editor of two quarterly web-based newsletters, the PUFA Newsletter for health professionals, and the consumer newsletter Fats of Life, both at (www.fatsoflife.com). She has published in the scientific and lay literature and given many talks on the health aspects of omega-3 fatty acids and seafood.
Dr. Nettleton holds a doctorate in nutrition science from the Harvard School of Public Health and a Masters in International Nutrition from Cornell. She is also a registered dietitian. In 1999, she was elected Fellow of the American Association for the Advancement of Science. When she is not eating seafood, she is chasing the black diamonds on Colorado's ski slopes or mastering the art of Argentine tango.
Abstract: COMMUNICATING RISKS AND BENEFITS OF DIETARY FATS: BEYOND SAFETY SCARES [PDF] |
Professor Kerin O’Dea Dept of Medicine, St Vincent’s Hospital, Melbourne, Australia |
 | Professor Kerin O'Dea AO has recently been appointed as a Professorial Fellow at the University of Melbourne (Department of Medicine, St Vincent's Hospital) and the Baker Heart Research Institute. Prior to this (2000-2005) she was Director of the Menzies School of Health Research in Darwin, NT. Her major research interests include lifestyle change and health in Aborigines and Torres Strait Islanders with particular emphasis on obesity, diabetes, cardiovascular and renal disease; diet in the pathogenesis, prevention and treatment of obesity, diabetes and cardiovascular disease in different population groups; and public health nutrition. |
Professor Harumi Okuyama Laboratory of Preventive Nutraceutical Sciences, Kinjo Gakuin University College of Pharmacy, Japan |
 | Harumi Okuyama, PhD, is Professor of Pharmacy at Kinjogakuin University College and a Professor Emeritus of Nagoya City University. He identified fatty acid synthetase as a thermo-receptor to modify membrane fluidity and revealed the presence of two phosphatidate synthesizing pathways. He has also contributed to establishing the essentiality of alpha-linolenic acid (ALA) for the maintenance of learning performance, the reversibility of ALA deficiency-induced alterations of brain functions, and the effectiveness of lowering omega 6:omega 3 ratio of foods for the prevention of cancers and allergic diseases. Currently, his work focuses on changing lipid nutrition for the prevention of diseases and on anti-nutritional factors in vegetable oils.
Abstract: HIGH BLOOD CHOLESTEROL AS PREDICTOR FOR LOW CANCER MORTALITY AND LONGEVITY [PDF]
Abstract: DIETARY FATS AND LONGEVITY [PDF] |
A/Professor Susan Prescott, School of Paediatrics & Child Health, University of Western Australia, Perth, Australia |
 | Susan Prescott is internationally recognised for her research in the area
of allergy and early immune development. She is a full time academic in the
School of Paediatrics and Child Health at University of Western Australia.
She is also a Paediatric Allergist and Immunologist at Princess Margaret
Hospital for Children. In addition to her clinical and teaching
responsibilities, she established and continues to run a growing clinical
and laboratory research group within the University School of Paediatrics
and Child Health. The main focus of her research group is the developing
immune system during foetal and early postnatal life.
Abstract: PRENATAL FATTY ACID EXPOSURE AND EARLY IMMUNE DEVELOPMENT [PDF] |
Dr Stanley Rapoport Brain Physiology & Metabolism Section, National Institute on Aging, USA |
 | Dr Rapoport is Chief of the Brain Physiology and Metabolism Section at the National Institute on Aging in Bethesda. He graduated from Harvard Medical School, did a Medical Internship at Bellevue Hospital in New York City, then postdoctoral work at Uppsala University in Sweden. At the NIH, he contributed to understanding the blood-brain barrier and to brain imaging in human aging and Alzheimer disease. Over the last 20 years, his group has applied an in vivo method to quantify and image the kinetics of arachidonic and docosahexaenoic acid metabolism in brain phospholipids of rodents and, more recently, in humans using positron emission tomography.
Abstract: WHAT ARE THE NORMAL RATES OF HUMAN BRAIN METABOLISM OF ARACHIDONIC AND DOCOSAHEXAENOIC ACIDS, AND WHAT MAY HAPPEN WHEN THEIR METABOLIC BALANCE IS ALTERED BY DIETARY N-3 PUFA DEPRIVATION? [PDF] |
Dr Rudolph Riemersma Cardiovascular Research Unit, Edinburgh, UK |
 | Rudolph Riemersma is Senior Lecturer in Cardiac Biochemistry and Professor Medical Physiology in Tromsø, Norway. His main research interest is in the biochemistry of acute coronary arterial disease and in the nutritional and epidemiological aspects of coronary heart disease in man. He has examined the role of fat and glucose metabolism in the development of heart failure in the genetically obese mouse (ob/ob). His case-control studies on the role of dietary fatty acids and antioxidants, heavy metals and "oxidative stress" in acute myocardial infarction, sudden cardiac death and unstable angina and on the progression of atherosclerosis in man have received wide attention. He is a member of a Cochrane Library Study group on dietary modification to reduce coronary heart disease. He is a member of the SIGN Guideline Development Group (Cardiovascular Disease Prevention, Nutrition), Editor of Atherosclerosis and the European Journal of Lipid Science and Technology.
Abstract: n-3 FATTY ACIDS, MORTALITY AND CORONARY HEART DISEASE: EVIDENCE FROM RANDOMISED CONTROLLED TRIALS [PDF] |